Vertex (VRTX) Beats on Q3 Earnings & Sales, Raises ’21 View Posted byZacks Equity Research November 3, 2021 Leave a comment on Vertex (VRTX) Beats on Q3 Earnings & Sales, Raises ’21 View Vertex Pharmaceuticals’ (VRTX) earnings and sales beat estimates for the third quarter of 2021. The company raises its product revenue guidance for the year.